Michael Morse, MD, FACP, MHS, medical oncologist at Duke Cancer Center, explained gaps in care access and equity that must be addressed to ensure all patients with liver cancer can get the treatments they need.
Michael Morse, MD, FACP, MHS, professor of medicine at Duke University School of Medicine and medical oncologist at Duke Cancer Center, explained gaps in care access and equity that need to be addressed to ensure all patients with liver cancer can get the care and treatments they need.
Transcript
What gaps need to be addressed to improve equity and access to care for patients with liver cancer?
One of the most critical aspects of the best outcome for any patient across any demographics is really getting a multidisciplinary evaluation because we have many therapies for cancer and liver cancer. We have surgeries, ablations, locoregional therapies that involve vascular delivery of therapies, and then we have systemic therapies, and of course, transplant as well—and I don't think any one clinician can know for certain whether one or another strategy is absolutely the best for a particular patient, and whether to discount any.
There are some obvious metrics: if you have very advanced disease, you're not going to be a transplant candidate, for example. I think it's still very helpful for people to get that multidisciplinary evaluation of some sort. It doesn't necessarily have to be in a particular clinic, doesn't have to necessarily be a conference, but that just discussions have been held—and obviously taking into account patient preferences as well, and their comorbidities. That's really going to drive outcomes.
One of the problems is many people don't have access to all of those opinions, and I think that's really where the effort needs to be put into. Although there certainly could be biases, both historical and contemporary, and financial issues, and other social issues that certainly do impact care—we have to try to mitigate those as much as we possibly can—it's ultimately reflected in whether people get that full review, and then once they get the review, are able to get the particular therapy that appears to be best for them.
And then once they've had a particular therapy, keep asking those questions, because now that we have more effective systemic therapies, for example, we are seeing people who can go back and have a locoregional therapy or even a surgery in rare instances, or transplant. I think that it's important that people also still have access to centers that can provide all this care, at least opinions, to people. So, how do we make sure that people that aren't in a major center, or it's more challenging to make the trip, or financially you're having difficulty accessing those drugs [can get access]? Obviously, we have to work on all of those problems.
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Managed Care Reflections: A Q&A With Hoangmai H. Pham, MD, MPH
April 1st 2025To mark the 30th anniversary of The American Journal of Managed Care® (AJMC®), each issue in 2025 will include a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The April issue features a conversation with Hoangmai H. Pham, MD, MPH, a member of AJMC’s editorial board and the president and CEO of the Institute for Exceptional Care (IEC).
Read More
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More